VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
Therapeutic choices after hypomethylating agent resistance for myelodysplastic syndromes.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis. Bone Marrow Transplant. 2015 May; 50(5):668-72.
View in:
PubMed
subject areas
Adult
Aged
Amyloidosis
Autografts
Disease-Free Survival
Female
Follow-Up Studies
Heart Diseases
Humans
Male
Melphalan
Middle Aged
Myeloablative Agonists
Recurrence
Stem Cell Transplantation
Survival Rate
Transplantation Conditioning
authors with profiles
RICHARD E CHAMPLIN
MUZAFFAR H QAZILBASH
ROBERT ORLOWSKI
LUHUA WANG